Ömer Fehmi Tabak

24PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersDisease surveillanceNanomedicineInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 17, 2026
Evaluation of Vancomycin Therapeutic Drug Monitoring Strategies: Pharmacokinetic, Pharmacogenetic, and Clinical Perspectives in a Prospective, Real-World Cohort Study.

|Apr 27, 2026
Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye.

|Sep 23, 2025
The impact of cART on hepatic steatosis and fibrosis in treatment-naïve PLwHIV: A prospective cohort study.

Meryem Sahin Ozdemir, Yusuf Emre Ozdemir, Alperen Dogdas

|Sep 16, 2025
Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3.

Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı

|Jul 21, 2025
Next-generation sequencing of CCR5, CXCR4, and IFNAR1 variants in relation to HIV-1 disease progression and ART response.

Kubra Cigdem Pekkoc-Uyanik, Zeynep Gizem Todurga-Seven, Andleeb Shahzadi

|Jun 18, 2025
Efficacy of tenofovir alafenamide- or tenofovir disoproxil fumarate-containing regimens in adults with treatment-naïve HIV-hepatitis B co-infection.

Fehmi Tabak, Dilek Yıldız Sevgi, Esra Zerdali

Pageof 4

Frequent Collaborators

14 joint publications

Bilgul Mete

7 joint publications

Hayat Kumbasar Karaosmanoglu

5 joint publications

Ilker Inanc Balkan

4 joint publications

Vedat Hamuryudan